Apatinib Mesylate Combined With Albumin Binds Paclitaxel and Carboplatin or Cisplatinum as First-line Treatment for Stage II-IV Epithelial Ovarian Cancer Followed by Apatinib Maintenance Therapy:a Single-arm,Exploratory Clinical Study
Latest Information Update: 07 Dec 2023
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Paclitaxel (Primary) ; Rivoceranib (Primary)
- Indications Carcinoma; Ovarian cancer
- Focus Therapeutic Use
- 22 Oct 2020 New trial record